Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin in Fontan Physiology
NCT04463394Phase 1Completed
- Sponsor
- Stanford University
- Start
- Aug 2020
- Primary completion
- Feb 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of vasopressin in hypotension, sponsored by Stanford University. Primary endpoints: Change in systemic (aortic) blood pressure at 15 minutes, Change in pulmonary artery pressure at 15 minutes and 2 more. Started Aug 2020; status: completed.
02
Drugs
vasopressin
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT04463394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04463394.